Requires food manufacturers to disclose new food additives not reported to FDA.
Impact
The proposed legislation aims to enhance food safety and transparency by providing consumers with information regarding potentially harmful additives. Legislative discussions suggest that the bill will foster public trust in food products available in New Jersey by allowing individuals to make informed dietary choices. Through mandatory reporting and public disclosure, the bill could also promote accountability among food manufacturers, compelling them to adhere strictly to safety protocols while formulating food products.
Summary
Assembly Bill A3069, also known as 'Food Additive Disclosure Act', mandates that food manufacturers operating in New Jersey disclose certain information regarding food additives that have not been reported to the U.S. Food and Drug Administration (FDA). The bill particularly focuses on substances that manufacturers deem 'Generally Recognized As Safe' (GRAS) and are planned for use in food and non-alcoholic beverages within the state. Each manufacturer will need to submit an annual report detailing these additives, including their intended use, method of production, and safety data, which the state’s Department of Health will publish for public access.
Contention
Concerns have been raised about the implications of such regulatory measures on small food producers and cottage food businesses, which may be subject to the same rigorous disclosure requirements as larger manufacturers. Critics argue that the financial burden of compliance may disproportionately affect smaller entities, hindering their ability to operate. Furthermore, there are debates over the effectiveness and sufficiency of the disclosures; some stakeholders worry that merely informing the public may not necessarily guarantee improved safety, as established GRAS status can sometimes lead to complacency regarding rigorous safety evaluations.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25
Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25